Diabetes · 2010 · 92 citations · 33 references
Overall, our data identify GRK2 as an important negative regulator of insulin effects, key to the etiopathogenesis of insulin resistance and obesity, which uncovers this protein as a potential therapeutic target in the treatment of these disorders.
33
Lori D. Klaman, Olivier Boss, Odile D. Peroni et al. · Molecular and Cellular Biology · 2000 · 1.2K citations · Full text
Metabolic Disorder, Energy Expenditure, Tissue-specific Insulin Sensitivity +19
Insulin Signaling in Health and Disease
Morris F. White · Science · 2003 · 714 citations
Signaling Pathways, Insulin Signaling, Metabolic Syndrome +17
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Guadalupe Sabio, Madhumita Das, Alfonso Mora et al. · Science · 2008 · 580 citations · Full text